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Platelet-rich gel for the adjuvant treatment 
of wound healing of transposed flap for 
arteriovenous fistula in systemic scleroderma
Dear Editor,
End-stage renal failure (ESRF) requiring dialysis is a com-
plication of systemic sclerosis.
The challenge of performing a distal arteriovenous fis-
tula (AVF) on a scleroderma patient is mainly related to the 
thickness of the skin. Due to the excessive fibroproliferative 
response to tissue injury, the closure of the surgical site can 
lead to compression and clotting of the anastomosis. Skin flap 
may help the closure but it can be affected by non-healing 
skin ulcers. These ulcers are often slow healing and unrespon-
sive to traditional treatments; consequently, the patient’s 
quality of life and prognosis may be severely affected (1). 
We report the effects of a platelet gel for wound healing in a 
58-year-old male with scleroderma and renal failure, following 
AVF surgery. The skin suture compression caused the failure of 
the fistula on the day after the intervention (2). During a second 
look we performed a second anastomosis 3 cm over the previ-
ous one. We encountered the same anastomosis compression 
while we were closing the skin, even though the anastomosis 
was efficient. While the vessels were suitable for a good anasto-
mosis, the skin thickness caused by sclerodermia was the main 
issue for a negative outcome. We performed a second skin inci-
sion with an angle of about 60 degrees starting from the distal 
angle of the main incision, creating a skin flap (Fig. 1A).
This skin flap was transposed on the skin wound above 
the anastomosis and sutured with absorbable stitches on the 
subcutaneous layer and the side above the anastomosis with 
non-absorbable stitches. The skin wound above the anastomo-
sis was closed with no compression on the fistula, ensuring its 
good performance. The other side was left open (Fig. 1B). After 
5 days from the last operation we checked the wound (Fig. 1C).
To heal the wound left by the skin transposition we chose 
to apply heterologous platelet-rich gel (PRG) (3) (Fig. 1D), 
whose efficacy has been demonstrated in both in vitro and 
in vivo models (4).
Four-weekly medications were performed with this 
device. Before applying the PRG, the wound was cleaned 
each time with saline solution. After the application the gel 
was covered with Bactigras®.
After one week, the first granulation spots appeared 
(Fig. 2A). After two weeks, the wound cleaning showed that 
the granulation tissue covered all of the wound (Fig. 2B) and 
the wound edges appeared narrower. By the fourth week, 
with the last application of PRG, we obtained a coherent 
granulation (Fig. 2C). In the fifth week we just cleaned the 
wound and applied Bactigras® (Fig. 2D). 
We decided to treat the skin portion left open using het-
erologous PRG that was already used for the treatment of 
skin ulcers from systemic sclerosis (1). Satisfying results have 
been also achieved on uremic and diabetic patients suffer-
ing from diabetic ulcers, with ulcer healing and a reduction 
of disease-associated morbidity and lowering health-care 
costs (5). 
Our experience confirmed the utility of PRG on wound heal-
ing, particularly on a patient suffering from systemic sclerosis.
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Fig. 1 - Creation of a skin flap (A); partial closure of the skin of the 
flap (B); control after 5 days (C); application of platelet-rich gel (D).
Fig. 2 - Granulation after one week (A); granulation tissue after two 
weeks (B); last application of platelet-rich gel at fourth week (C); 
healing at fifth week (D).
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